SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-097121
Filing Date
2024-08-14
Accepted
2024-08-14 16:45:19
Documents
48
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q hcwb-20240630.htm   iXBRL 10-Q 1272551
2 EX-10.1 hcwb-ex10_1.htm EX-10.1 184347
3 EX-10.2 hcwb-ex10_2.htm EX-10.2 47197
4 EX-10.3 hcwb-ex10_3.htm EX-10.3 153916
5 EX-10.4 hcwb-ex10_4.htm EX-10.4 116505
6 EX-31.1 hcwb-ex31_1.htm EX-31.1 14888
7 EX-31.2 hcwb-ex31_2.htm EX-31.2 14766
8 EX-32.1 hcwb-ex32_1.htm EX-32.1 9576
9 EX-32.2 hcwb-ex32_2.htm EX-32.2 9326
  Complete submission text file 0000950170-24-097121.txt   4995711

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT hcwb-20240630.xsd EX-101.SCH 738777
50 EXTRACTED XBRL INSTANCE DOCUMENT hcwb-20240630_htm.xml XML 448345
Mailing Address 2929 N COMMERCE PKWY MIRAMAR FL 33025
Business Address 2929 N COMMERCE PKWY MIRAMAR FL 33025 954-842-2024
HCW Biologics Inc. (Filer) CIK: 0001828673 (see all company filings)

IRS No.: 825024477 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40591 | Film No.: 241208990
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)